Effect of levothyroxine on the pregnancy outcomes in recurrent pregnancy loss women with subclinical hypothyroidism and thyroperoxidase antibody positivity: a systematic review and meta-analysis

References

• Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2018(2):hoy004. doi:10.1093/hropen/hoy004.
   PubMedGoogle Scholar
• Dimitriadis E, Menkhorst E, Saito S, et al. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98. doi:10.1038/s41572-020-00228-z.
   PubMed Web of Science ®Google Scholar
• Leduc-Robert G, Iews M, Abdelkareem AO, et al. Prevalence of thyroid autoimmunity and effect of levothyroxine treatment in a cohort of 1064 patients with recurrent pregnancy loss. Reprod Biomed Online. 2020;40(4):582–592. doi:10.1016/j.rbmo.2019.11.014.
   PubMed Web of Science ®Google Scholar
• Dong AC, Morgan J, Kane M, et al. Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril. 2020;113(3):587–600.e1. doi:10.1016/j.fertnstert.2019.11.003.
   PubMed Web of Science ®Google Scholar
• Yu YH, Filion KB, Reynier P, et al. Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: a population-based assessment. Pharmacol Res Perspect. 2021;9(5):e00848. doi:10.1002/prp2.848.
   PubMed Web of Science ®Google Scholar
• Rao M, Zeng Z, Zhou F, et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(3):344–361. doi:10.1093/humupd/dmz003.
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Ebara T, Yamada Y, et al. Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: multiple imputation analyses with propensity score adjustment applied to a large-scale birth cohort of the Japan Environment and Children’s Study. Am J Reprod Immunol. 2019;81(1):e13072. doi:10.1111/aji.13072.
   PubMed Web of Science ®Google Scholar
• Dal Lago A, Galanti F, Miriello D, et al. Positive impact of levothyroxine treatment on pregnancy outcome in euthyroid women with thyroid autoimmunity affected by recurrent miscarriage. JCM. 2021;10(10):2105. doi:10.3390/jcm10102105.
   Google Scholar
• van Dijk MM, Vissenberg R, Fliers E, et al. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2022;10(5):322–329. doi:10.1016/s2213-8587(22)00045-6.
   PubMed Web of Science ®Google Scholar
• Dhillon-Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in women with thyroid peroxidase antibodies before conception. N Engl J Med. 2019;380(14):1316–1325. doi:10.1056/NEJMoa1812537.
   PubMed Web of Science ®Google Scholar
• Bliddal S, Feldt-Rasmussen U, Rasmussen ÅK, et al. Thyroid peroxidase antibodies and prospective live birth rate: a cohort study of women with recurrent pregnancy loss. Thyroid. 2019;29(10):1465–1474. doi:10.1089/thy.2019.0077.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, W64. doi:10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 2022 May 25]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12. doi:10.1016/0197-2456(95)00134-4.
   PubMedGoogle Scholar
• Chen X, Lu M, Xu W, et al. Treatment of pediatric femoral shaft fractures with elastic stable intramedullary nails versus external fixation: a meta-analysis. Orthop Traumatol Surg Res. 2020;106(7):1305–1311. doi:10.1016/j.otsr.2020.06.012.
   PubMed Web of Science ®Google Scholar
• Li X, Dai J. Effect of levothyroxine on pregnancy outcomes in patients with TPOAb‐positive recurrent spontaneous abortion. Chin J Woman Child Heal Res. 2018;29(9):1097–1100. doi:1673-5293(2018)09-1097-04.
   Google Scholar
• Bai N. Effect of levothyroxine on the pregnancy outcomes in recurrent abortion patients with thyroid peroxidase antibody positive. Cap Food Medi. 2019;26(22):51. doi: 1005-8257(2019)11-0051-01.
   Google Scholar
• Bernardi LA, Cohen RN, Stephenson MD. Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss. Fertil Steril. 2013;100(5):1326–1331. doi:10.1016/j.fertnstert.2013.07.1975.
   PubMed Web of Science ®Google Scholar
• Mosaddegh MH, Ghasemi N, Jahaninejad T, et al. Treatment of recurrent pregnancy loss by levothyroxine in women with high anti-TPO antibody. Iran J Reprod Med. 2012;10(4):373–376.
   PubMedGoogle Scholar
• Yan J, Sripada S, Saravelos SH, et al. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy. Fertil Steril. 2012;98(2):378–382. doi:10.1016/j.fertnstert.2012.04.025.
   PubMed Web of Science ®Google Scholar
• Vissenberg R, Fliers E, van der Post JA, et al. Live-birth rate in euthyroid women with recurrent miscarriage and thyroid peroxidase antibodies. Gynecol Endocrinol. 2016;32(2):132–135. doi:10.3109/09513590.2015.1092513.
   PubMed Web of Science ®Google Scholar
• Yoshihara H, Sugiura-Ogasawara M, Goto S, et al. Levothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss. Am J Reprod Immunol. 2021;85(3):e13341. doi:10.1111/aji.13341.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xiao L. To investigate the effect of levothyroxine treatment and prednisone combined with aspirin in patients with recurrent spontaneous abortion of TPOAb positive. Chin J Birth Heal Heredity. 2018;26(1):60–61. doi:10.13404/j.cnki.cjbhh.2018.01.027.
   Google Scholar
• Zhang X, Geng C, Ren Z, et al. The effect of levothyroxine on pregnancy outcome of recurrent spontaneous abortion with subclinical hypothyroidism. Chin J Fam Plan Gyn. 2021;13(10):71–78. doi:10.3969/j.issn.1674-4020.2021.10.17.
   Google Scholar
• Duan X. Effects of levothyroxine tablets on thyroid function and pregnancy outcome in patients with TPOAb positive recurrent spontaneous abortion. Sichuan J Phys Sci. 2019;41(1):22–24.
   Google Scholar
• Wang L, Chen H. Study on the therapeutic value of levothyroxine tablets for recurrent abortion patients with thyroid peroxidase antibody positive. Our Health. 2020;2020(6):151. doi: 1002-8714(2020)06-0151-01.
   Google Scholar
• Kuroda K, Ikemoto Y, Horikawa T, et al. Novel approaches to the management of recurrent pregnancy loss: the OPTIMUM (OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu) treatment strategy. Reprod Med Biol. 2021;20(4):524–536. doi:10.1002/rmb2.12412.
   PubMed Web of Science ®Google Scholar
• Godlewska M, Gawel D, Buckle AM, et al. Thyroid peroxidase revisited - what’s new? Horm Metab Res. 2019;51(12):765–769. doi:10.1055/a-1057-9469.
   PubMed Web of Science ®Google Scholar
• De Leo S, Pearce EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018;6(7):575–586. doi:10.1016/s2213-8587(17)30402-3.
   PubMed Web of Science ®Google Scholar
• Uchida S, Maruyama T, Kagami M, et al. Impact of borderline-subclinical hypothyroidism on subsequent pregnancy outcome in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol Res. 2017;43(6):1014–1020. doi:10.1111/jog.13319.
   PubMed Web of Science ®Google Scholar
• Pfeifer S, Fritz M, Goldberg J. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103–1111. doi:10.1016/j.fertnstert.2012.06.048.
   PubMed Web of Science ®Google Scholar
• Leng T, Li X, Zhang H. Levothyroxine treatment for subclinical hypothyroidism improves the rate of live births in pregnant women with recurrent pregnancy loss: a randomized clinical trial. Gynecol Endocrinol. 2022;38(6):488–494. doi:10.1080/09513590.2022.2063831.
   PubMed Web of Science ®Google Scholar
• Di Girolamo R, Liberati M, Silvi C, et al. Levothyroxine supplementation in euthyroid pregnant women with positive autoantibodies: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:759064. doi:10.3389/fendo.2022.759064.
   PubMed Web of Science ®Google Scholar
• Zhou G. Effect of thyroid peroxidase antibody and thyroglobulin antibody on pregnancy outcomes. Matern Child Heal Care Chin. 2018;33(7):1501–1503.
   Google Scholar
• Okuroglu N, Ozdemir A, Sertbas Y, et al. The relationship between thyroid antibody titer and levothyroxine dose in patients with overt primary hypothyroidism. Ann Saudi Med. 2017;37(3):189–193. doi:10.5144/0256-4947.2017.189.
   PubMed Web of Science ®Google Scholar